Table 5 Quality assessment of the included studies
From: Point-of-care testing in private pharmacy and drug retail settings: a narrative review
Ref no | Author | Published year | Target Disease | Randomized research design used | Availability of external control group | Multiple single centre? | Sustainability of the intervention sufficiently assessed (> 12 months) | Sample size calculation (except for qualitative studies) | Prospective data collection | Correction for confounding factors | Total no. of criteria met (out of 7) |
|---|---|---|---|---|---|---|---|---|---|---|---|
[23] | Ansah | 2015 | Malaria | 0 | |||||||
[35] | Audu | 2016 | Malaria | 0 | |||||||
[36] | Aung | 2015 | Malaria | ✓ | 1 | ||||||
[24] | Awor | 2014 | Malaria and pneumonia | ✓ | ✓ | 2 | |||||
[37] | Awor | 2015 | Malaria and pneumonia | ✓ | ✓ | 2 | |||||
[38] | Cohen | 2012 | Malaria | ✓ | ✓ | 2 | |||||
[26] | Hansen | 2017 | Malaria | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 7 |
[39] | Hutchinson | 2015 | Malaria | ✓ | ✓ | ✓ | ✓ | Qualitative | ✓ | 5 | |
[40] | Hutchinson | 2017 | Malaria | ✓ | ✓ | ✓ | ✓ | Qualitative | ✓ | 5 | |
[41] | Ikwuobe | 2013 | Malaria | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | ||
[42] | Kitutu | 2017 | Malaria, pneumonia and bloody diarrhoea | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | |
[43] | Kwarteng | 2019 | Malaria | ✓ | ✓ | ✓ | 3 | ||||
[44] | Maloney | 2017 | Malaria | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 7 |
[34] | Mboyne | 2015 | Malaria | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 7 |
[46] | O' Meara | 2016 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||
[47] | Poyer | 2018 | Respiratory tract infections | ✓ | ✓ | ✓ | ✓ | 4 | |||
[49] | Simmalavong | 2017 | Malaria | ✓ | ✓ | ✓ | 3 | ||||
[51] | Sudhinaraset | 2015 | Malaria | ✓ | ✓ | 2 | |||||
[52] | Thet | 2021 | Malaria | ✓ | ✓ | ✓ | 3 | ||||
[45] | Onwunduba | 2022 | Malaria | ✓ | ✓ | ✓ | 3 | ||||
[50] | Soniran | 2022 | Malaria | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | |
[48] | Shelus | 2023 | Malaria | ✓ | ✓ | 2 |